PFE PDUFA decision: an FDA approval, +0.4%

On July 10, 2025, PFIZER reached its PDUFA decision. The result was an FDA approval, and the stock moved +0.4% in the window around the event. It had already run +7.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.